chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I tested positive for COVID 19 on 11/27/20.  A chest scan was done on 12/6/20 and showed mild pneumonia.  I was treated with Azithromycin and Prednisone.  This was followed a a course of Cefdinir.  A follow up chest scan on 12/28/20 showed  "interval resolution of previously identified right lung base opacities".
12 hours after vaccine I awoke with chills and body aches which continued thru the night and into the next day.  Temp. peaked at 100.8 degrees that day at 2 pm.   Nausea with one episode of vomiting.  Extremely tired and slept most of the day.  Tylenol ES 1 capsule taken at 2 pm on 4/24  and symptoms gradually started to decline. (no adverse reaction after the first injection 28 days prior)
Caller had Lumps in his armpits after he received the 2nd dose of Vaccine; This is a spontaneous report from a Pfizer-sponsored program. A male contactable Consumer or other non HCP (patient) of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported) via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced caller had lumps in his armpits after he received the 2nd dose of vaccine on an unspecified date. Outcome of event was unknown.    Follow-up attempts are completed. No further information is expected.
first dose of the vaccine on November 15th, 2019 / not yet received the second dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first dose of Shingrix on 15th November 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The patient received had not yet received the second dose of Shingrix, which led to incomplete course of vaccination. No further events were reported. The reporter consented to follow up.
Shot administered on 6 November 2002 Swelling left arm joint pain left arm.  Swelling started to go down after 48 hours. After swelling went down lump remained at site of vaccination. member is now itching at the site of swelling.
This is a spontaneous report from a contactable consumer. A 65-year-old female patient received the second dose of BNT162B2 at 65-year-old, via an unspecified route of administration in arm left on 31Aug2021 11:00 (Batch/Lot Number: EWO164) at single dose for COVID-19 immunisation. Medical history included lupus, cerebrovascular white matter disease, and known allergies: Contrast dye used in Cat Scans severe anaphylaxis. Concomitant medications included acetylsalicylic acid (ASPIRIN), ascorbic acid (VIT C), colecalciferol (VIT D3), zinc, and ubidecarenone (COQ-10). Patient previously received the first dose of BNT162B2 at 65-year-old in left arm on 04Aug2021 08:00 (Lot number: EWO164) for COVID-19 immunisation and tolerated fairly well. On 31Aug2021 13:00, patient experienced bruise at injection site lasting ten day with pain, and having Lupus, it felt as though she had a lupus "flare-up" within hours of receiving the second vaccine, which she had not had this severely, in a number of years. Symptoms included fever, severe fatigue, weakness, transient nerve and muscle pain, increased arthritis pain and stiffness on left side, especially left hand and significant "brain fog", confusion and memory challenges (patient also had cerebrovascular white matter disease and second injection seemingly exacerbated symptoms). After two weeks following the second injection, symptoms decreased, but still remained at a lesser degree. For two years, patient had more or less, maintained stability with lupus symptoms, without use of medication through healthy living and daily cardiovascular exercise. After the second vaccine, there was an overwhelming feeling of a great deal of inflammation in her system. No treatment received for these events. Outcome of events bruise at injection site lasting ten day with pain was resolved, and of other events was resolving. Follow-up attempts are completed. No further information is expected.
Two days after my first dose vaccine, I lost all sense of taste and smell. I also had pain at the site of injection.
very high fever next day after vaccine, 102.2, body chils and aches,  following day sore muscles, then in the evening started seeing floaters and flashes from the corner of the right eye.  Never had any issues with eyes prior to vaccine.  went to Optomentrist on Monday April 12th, did scan of eyes.  Doctor did not see anything wrong.  Yet I still see floaters and flashes from the corner of my right eye.
Patient developed pain in the are of vaccination on 9/14/2017, reported itching to area as well.  On evaluation, some warmth over the injection area noted, with erythema and mild swelling distal and more medial to the injection site.
Sore arm; tired; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 15Apr2021 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration on 25Mar2021(at the age of 59-years-old) as a single dose for COVID-19 immunisation. On 15Apr2021, the patient experienced sore arm and tired. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore arm and tired was resolved on an unknown date in 2021.   The lot number for BNT162b2 was not provided and will be requested during follow up.
Product lot number issue; Patient does not report signs/symptoms of adverse effects.; HCP called to report TE regarding GARDASIL 9. GARDASIL 9 was administered after the TE (TE case 02448226); This spontaneous report was received from a pharmacy technician and refers to a 12-year-old patient of unknown gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On 27-JUL-2023, the patient was vaccinated with the second dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) intramuscular injection administered intramuscularly for prophylaxis (strength not provided) (Product storage error). Reporter reported quadrivalent human GARDASIL with lot #W009829 which was not valid for GARDASIL. However, lot #W009829 was valid for hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (Product lot number issue), expiration date: 19-OCT-2024. Patient did not report signs/symptoms of adverse effects (No adverse event).
Hives, itching and angioedema requiring ER visit. One week later exposed to flu vaccine that had leaked from a multi dose vial and had full anaphylactic reaction requiring another ER visit and hospitalization.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2016, the patient was inoculated with ZOSTAVAX by a physician as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. Later in 2016, the patient was treated by another physician for a blistering vesicular outbreak which was diagnosed as herpes zoster or shingles. The patient was prescribed VALTREX for management of his painful symptoms and chronic pain. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related.
It all started 12/1/2021 in the PM, she had a low grade fever and it lasted for a week. She stated that she had a pain in her chest and it was a very short pain and it didn't last very long. It went away and her fever persisted. She then started complaining about her throat starting to hurt on December 5, 2021 and she thought her tonsils was coming back, because she had them removed when she was 3 years old. On December 6, 2021, I took her in to see her pediatrician and they tested her for COVID and Strep and they both were negative. She did see some redness on her throat. The doctor told me to continue to keep and eye on her and the fever she was running. Parent said that her fever wasn't over a 100 F, it was a low grade fever. She stated that she didn't want daughter to give the toddler anything. That's why she took her in to see the doctor.
Patient felt flu-like symptoms and difficulty breathing for 2 days post vaccine. Patient is feeling better now.
Flushing 10 min after injection followed by heart palpitations then increased blood pressure.  I took 2 loratidine tablets and symptoms slowly subsided over the next 50 min. The next day had chills and nausea for 8-10 hr.  The nausea lasted another 3-4 days.
85kg 5'4" 36yo WF with PMH asthma, anxiety, celiac dx, heart palpitations, lumbar disc dx, migraine sciatica, allergy to shellfish and fish and multiple drug allergies presented to get her second dose of Pfizer Covid-19 vaccine on 5/25.  First dose had been given 5/2/21 (lot # #EW0179) in left deltoid.  After 1st shot, patient had neck and arm pain and diarrhea the first 12 hrs.  Sought medical attention at urgent care on 5/7 for back ache, low grade fever, sore throat, foggy headed feeling, mild intermittent nausea and diarrhea.  Symptoms attributed to Covid19 vaccination.   Second Covid19 vaccine (same lot) given in left deltoid at 1536 5/25.  5 minutes after receiving the vaccine, patient complained of tongue tingling, feeling flushed, sharp chest pain, burning on face, itching and SOB.  Patient had rash on check and neck.  Hives appeared.  Patient wheezing.  Patient reported reaction was similar to reaction to fish.  Patient's own epinephrine pen was expired.  Pt assisted to recline and legs elevated.  VSS.  BP 130/80s, HR 100's RR 20; O2 99% on RA.  EMS was called.  0.3mg IM epinephrine given ~1550 while waiting. EMS treated with 50mg diphenhydramine, 20mg famotidine and ondansetron 4mg IV at 1610.  Symptoms improved but returned so another 0.3mg epinephrine IM was given at 1620.  Transferred to ED where patient c/o nausea, tingling of chest/lips and throat stinging.  Epinephrine 0.5mg IM charted as given.  Tachycardic from epinephrine administrations.  Treated with dexamethasone 4mg po at 1941 as patient reported reacting to methylprednisolone.   Patient discharged 5/25 PM.  Patient reported recurrence of flushing, mouth tingling and nausea but refused to seek treatment at UC or ED.  Advised to take Claritin or Zyrtec.  Patient saw physician covering her PCP on 5/28/21. On that day, patient reported she was having waves of feeling flushed or hot over the last few days and her tongue is still slightly tingly but she denies swelling of lips or throat, chest pain, palpitations.  Covid-19 vaccine allergy was added to this patient's allergy list.
Pt c/o pain in the arm since receiving a flu shot. Initially, she was seen in the office for this 9/28/2015 and again 11/23/2015 because the arm still hurts.
Patient had limitation of arm movement, pain and swelling at the injection site. > 1 week advised patient to contact PCP if symptoms persist. Self care - acetaminophen and ice.
Fever on 5/17/2000 PM with possible febrile seizure. 2nd febrile seizure on 5/18/2000. Pt transferred to Medical Center. Also diagnosed with apnea and rhinorrhea.
BLOOD SUGAR INCREASED 40-50 POINTS; This spontaneous report received from a patient concerned a 58 year old female. The patient's weight was 269 pounds, and height was 55 inches. The patient's past medical history included anxiety, and depression, and concurrent conditions included diabetes type ii (non-insulin), fish allergy, high blood pressure, asthma, arthritis, alcoholic, and non smoker, and other pre-existing medical conditions included the patient did not have any history of drug abuse or illicit drug use. The patient was not pregnant at the time of vaccination. The patient experienced drug allergy when treated with sulfamethoxazole/trimethoprim. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805031 expiry: 26-MAY-2021) dose was not reported, administered on 25-MAR-2021 for prophylactic vaccination. Concomitant medications included glipizide for diabetes type ii (non-insulin), and metformin hydrochloride for diabetes type ii (non-insulin). On APR-2021, the subject experienced blood sugar increased 40-50 points. Laboratory data included: Blood glucose (NR: not provided) Sugar increased 40-50 points. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of blood sugar increased 40-50 points was not reported. This report was non-serious.
1 day after Td administered, pt noted left side of neck, cramping and difficult to swallow. Within 2 days after vaccine, pt had left sided facial numbness and weakness. Left eye and mouth drooping. Pt unable to lift smile on left side or left eyebrow.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Numbness (specify: facial area, extremities)-Medium, Additional Details: Patient said her arm started to feel numb right after the injection. she waited here for a little bit then left to go home but then came back because her cheek started to go numb.  We gave her some water and she sat down for about 20 minutes, said she felt like she was going to faint. we sat her down in the back on the floor and her dad came to get her. They left and ended up going to the ER because the numbness started spreading to her leg and she said she had trouble walking.
TaP given on 12/11/2001 in LT. On 12/13/01 a red area, measuring 9 cm X 5.5 cm and warm to the touch appeared at the injection site.
This spontaneous report as received from a pharmacist via a field employee refers to a patient of unknown age (reported as "medicare age") and gender. On an unknown date the patient was vaccinated with a single dose of ZOSTAVAX (dose 0.65 ml, subcutaneous, lot# and expiration date were not reported). After the dose was given, the pharmacist looked at the patient's records and find out that the ZOSTAVAX was given previously on an unspecified date. No adverse event was reported. Additional information has been requested.
have the bruises around her finger and her fore arm; This is a spontaneous report from a contactable consumer. A female patient (reporter's mother) of an unspecified age received second dose of (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received first dose of (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) at single dose for COVID-19 immunisation. It's reported after the second dose when she woke up "today" she have the bruises around her finger and her fore arm. The outcome of the event was unknown.  Comment: As reporter hung up the call abruptly. Hence further probing could not be done. Limited information available over the call. Communication: Reason of delay: Daily spike of incoming calls due to COVID19 vaccine.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Was talking with patient, became quiet and just fell to the side of the exam table, at that point I caught her and laid her back. Only lasted about one minute. When she woke, she said that she thought that she fell asleep. She has done this previously with blood draws and injections. BP 110/60, pulse 46. After resting about 15 minutes BP was 110/70 and pulse 74. States she feels fine to leave the office.
When administering the vaccine, most of the dose leaked out of the side where the syringe is attached to the needle. Less than half of the dose was administered. Following CDC guidance, since it was less than half a dose administered, a second full dose was administered to the opposite arm. Patient was in no distress and remained stable during the entire procedure. Patient was observed for 15 minutes following the vaccine administration and no adverse reaction was noted.
This spontaneous report as received from a pharmacist via a company representative refers to a unspecified amount of patients of unknown age and gender. Medical history and concurrent conditions were not reported. On an unknown date the patients were vaccinated with ZOSTAVAX. Dose, route and lot number were not reported. No co-suspect and concomitant therapies were reported. The physician reported that unspecified amount of patients developed an unspecified staphylococcus infection at an unspecified time after receiving ZOSTAVAX. He reported that "some" of the unspecified patients sought out medical attention an unspecified way at unspecified time. He also reported hospitalization for an unspecified amount of patients due to the unspecified staphylococcus infection at an unspecified time. At the time of this report the outcome of unspecified staphylococcus infection was unknown. The causality was not reported. Additional information has been requested.
R04.0 - Frequent nosebleeds ABDOMINAL PAIN NOSE BLEED HEADACHE
Patient developed itching of ears,hands, generalized hives, swollen eyes and facial swelling within 30 minutes of receiving vaccine. Patient was seen in ER by 9:30 am. Patient was given IV solumedrol and Benadryl, was sent home with 4 days of steriods and Benadryl.
chills; fever; muscle aches; nausea; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (fever), MYALGIA (muscle aches), NAUSEA (nausea) and FATIGUE (fatigue) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024MZ0A) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced CHILLS (chills), PYREXIA (fever), MYALGIA (muscle aches), NAUSEA (nausea) and FATIGUE (fatigue). At the time of the report, CHILLS (chills), PYREXIA (fever), MYALGIA (muscle aches), NAUSEA (nausea) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
I had my first covid vaccine shot on 5/15/21 with no side effects. I had my second vaccine shot on 6/5/21 and had a change in my smell and taste 3 days later. I did not loose my taste and smell. Everything smells and tastes different since my second vaccine shot. I saw my doctor three months later for these symptoms. There was no explanation for these symptoms. The doctor thinks it may be from the vaccine.
The patient was administered the 2nd shot of the Pfizer COVID vaccine on Day 14 instead of Day 21. The patient did not report any adverse effects.
pt recv vax; soreness in shoulder from joint to neck; pain in sternum, pain just behind collar bone;at times becoming shaft pain down to stomach;
Long sock type of paresthesia , bilateral: Slight decrease sensation (touch); Recent notation of loss of vibration sensation. feet colder than normal. This started within a month of receiving the 2nd vaccination. Gradual improvement over past 10 months. Recent Pfizer booster shot had no effect on the loss of sensation. Overall effect has improved from the sensation of wearing a tall neoprene stocking to a shorter sock.  No other symptoms (no involvement with hands or arms). No muscle weakness
Narrative:  Other Relevant Hx: Symptoms:  Diarrhea, NauseaVomiting & cold sweats, weakness
Hive type red, raised, oblong rash developed evening of 12/11/09 on chest and abdomen. Next day had spread to back, with two spots on child's fact by the third day. By third day, rash began to darken and flaten.  Denies itching, using Aquaphor cream. Rash remains as of 12/16/2009. Mother indicated positive allergy test to peanuts and eggs five years ago. Eats eggs without problems. Screening questions indicated no egg allergy.
Started coughing at 2:15pm and unable to stop, became blushed with chest tightness, throat was scratchy. VS taken and stable, MERT was call and was sent to ER. IV started and Solumedrol, benedryl, and pepsid administered. After 15-20 minutes coughing stopped.
A report has been received from a Health Professional concerning a 68 year old, male patient. On unknown date, the patient received FLUMIST QUADRIVALENT (intranasal). The patient was above the appropriate age for receiving the vaccine on 21-Sep-2014. The outcome of the event of administered FLUMIST to two patients over 49 was unknown. The report was considered to be non-serious by reporter.
4 year-old vaccines (DtaP, MMR and Varicella, IPV) given 08/16 here with right upper arm induration along ingestion site starting this morning.  Improving with MOTRIN, ice.
Reported an onset of right thumb weakness one day post vaccination with AVA. Per record review pt was vaccinated with AVA # 3 on 30 SEP 13. No problems with previous immunizations. Reported small amt localized pain at immunization site, without swelling and denied thumb pain or altered sensation. Per records pt reports that strength is returning and there remains a measurable weakness with the right thumb.
This spontaneous report as received from a nurse refers to multiple unspecified patients of unknown age and gender. On an unknown dates, in 2014 (reported as "since October 2014") the patients were vaccinated with improperly stored RECOMBIVAX HB, (therapy type, dose, route, lot# and expiration date were not reported). No adverse effects were reported. No PQC (product quality complaint) was involved. This is the one of several reports received from the same reporter. Additional information has been requested.
90 minutes after vaccine, Right hand and right foot became tingly and numb suddenly. The feeling traveled to the left hand and foot. Progressively got worse. In the following days, numbness and tingling traveled to wrists and ankles too.
Narrative: Covid+, Moderna #2, 89 year old with baseline confusion. lethargy, vomiting, diarrhea, increased confusion, SOB. Dex, ceftriaxone, azithromycin. d/c home with home health